AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2004
(RS. IN LACS)
PARTICULARS
9 months
3 months
3 months
Year
Year
ended
ended
ended
ended
ended
31.12.2003
31.03.2004
31.03.2003
31.03.2004
31.3.2003
Audited
Audited
Audited
Audited
Audited
Net Sales/Operational Income
12129.87
4522.28
4085.43
16652.16
14480.65
Others Income
71.37
121.74
38.55
193.11
72.46
TOTAL EXPENDITURE :
10676.20
4012.47
3635.71
14688.67
12898.20
(a) Increase/decrease in stock in trade
651.63
24.25
-698.77
675.87
-178.49
(b) Consumption of Raw Material
9140.90
3115.51
2341.95
12256.41
10723.15
(c) Staff Cost
176.26
68.95
54.11
245.21
200.87
(d) Other expenditure
2010.67
852.26
540.88
2862.92
1795.69
Interest
515.15
193.16
195.03
708.31
675.85
Depreciation
198.83
79.84
63.68
278.67
233.45
Profit(+)/Loss(-) before tax
811.06
358.56
229.56
1169.62
745.62
Provision for taxation
59.33
16.15
25.36
75.48
60.10
Provision for deferred tax
157.55
167.43
92.19
324.98
153.43
Net Profit/Loss
594.18
174.99
112.01
769.17
532.09
Provision for Dividend on Preference Shares
3.51
1.86
3.51
7.43
Provision for Preference Dividend Tax
0.45
0.24
0.45
0.95
Profit available for Equity shareholders
171.03
109.91
765.21
523.71
Provision for dividend on Equity Shares
156.13
0.00
Provision for Equity dividend tax
20.01
0.00
Transfer to General Reserve
76.92
0.00
Retained Profit
512.16
523.71
Paid up Equity Share Capital
1561.37
1304.63
Reserve
3581.75
2551.66
EPS Rs.
Basic
4.18
1.17
1.00
5.24
4.78
Diluted
4.18
1.09
1.00
4.87
4.78
Aggregated on Non-Promoters Shareholding
No.
of Shares
9779594
7124289
% of Shareholding
62.63%
54.61%
Notes:
a) During the year the turnover rose by 15.39%
and the net profit rose by 44.56%. During the last Quarter of the FY the profits
rose by over 55.34% and turnover rose by 11% as compared to the figures of the corresponding
period in the previous year.
b) To Strengthen its presence in the Regulated
Markets and to expand the C-R-A-M-S business the Company has set up a Wholly Owned
Subsidiary in US
c) The board has recommended a dividend at the
rate of 1% on 3,50,540 Non-Cumulative Preference shares of the Company
d) The board has recommended 10% dividend on
the equity shares of the Company .
e) There was one complaint pending at the beginning
of the quarter, 28 complaints were received during the quarter, which were duly
redressed to the satisfaction of shareholder. There was only one complaint pending
as on 31.03.2004.
f) The management information system of the
Company identifies and monitors “ Pharmaceuticals” as the business
segment .
g) The previous period figures have been
regrouped and rearranged wherever necessary.
i) The above audited results were taken on record
by the Board of Directors in its meeting held on 28th June, 2004.
For Ind-Swift Laboratories Limited
Sd/-
Sd/-
Place:Chandigarh
(N.R.MUNJAL)
(V.K.MEHTA)
Date:30.06.2004
Managing Director
Jt.Managing Director
To know about our Formulation Division, please visit us at
Ind-Swift Limited, our other group company.
